Metformin (Elderly)
Brand names: Glucophage
This page covers metformin in older patients; it is a biguanide and first-line oral agent for type 2 diabetes, with renal-function-guided use being the key consideration in this group.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity and glucose uptake, lowering blood glucose without directly stimulating insulin secretion.
Prescribing in practice
- Dosing depends on renal function, which declines with age; reduce or avoid in significant renal impairment because of the risk of lactic acidosis, and apply sick-day rules during acute illness or dehydration.
- Withhold around the time of iodinated contrast imaging and major surgery where renal function may deteriorate, then restart once renal function is confirmed stable.
- Long-term use can cause vitamin B12 deficiency, which is worth considering in older patients with anaemia or neuropathy.
Monitoring
Monitor renal function before starting and periodically thereafter, along with glycaemic control and, where indicated, vitamin B12 status.
Counselling the patient
- Take with food to reduce stomach upset; modified-release forms may help if this is troublesome.
- Pause it and seek advice if you become dehydrated or acutely unwell (sick-day rules).
- Attend regular blood tests to check kidney function and diabetes control.
Evidence & guidelines
The UK Prospective Diabetes Study established metformin as first-line therapy, and NICE supports renal-function-guided dosing with temporary withholding during acute illness.
Reference: NICE NG28; UKPDS; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Berg Balance Scale (BBS) · Rehabilitation
- Timed Up and Go (TUG) Test · Mobility Assessment
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5